Hercules Capital Other Operating Income or Expenses 2010-2024 | HTGC
Hercules Capital other operating income or expenses from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Hercules Capital Annual Other Operating Income or Expenses (Millions of US $) |
2023 |
$-16 |
2022 |
$-13 |
2021 |
$-17 |
2020 |
$-12 |
2019 |
$-9 |
2018 |
$-8 |
2017 |
$-9 |
2016 |
$-5 |
2015 |
$-6 |
2014 |
$-6 |
2013 |
$-5 |
2012 |
$-4 |
2011 |
$-3 |
2010 |
$-1 |
2009 |
$-2 |
Hercules Capital Quarterly Other Operating Income or Expenses (Millions of US $) |
2024-09-30 |
$-4 |
2024-06-30 |
$-4 |
2024-03-31 |
$-3 |
2023-12-31 |
$-3 |
2023-09-30 |
$-4 |
2023-06-30 |
$-4 |
2023-03-31 |
$-4 |
2022-12-31 |
$-3 |
2022-09-30 |
$-4 |
2022-06-30 |
$-3 |
2022-03-31 |
$-3 |
2021-12-31 |
$-4 |
2021-09-30 |
$-4 |
2021-06-30 |
$-4 |
2021-03-31 |
$-4 |
2020-12-31 |
$-6 |
2020-09-30 |
$-2 |
2020-06-30 |
$-2 |
2020-03-31 |
$-2 |
2019-12-31 |
$-4 |
2019-09-30 |
$-1 |
2019-06-30 |
$-2 |
2019-03-31 |
$-3 |
2018-12-31 |
$-2 |
2018-09-30 |
$-2 |
2018-06-30 |
$-3 |
2018-03-31 |
$-1 |
2017-12-31 |
$-4 |
2017-09-30 |
$-1 |
2017-06-30 |
$-1 |
2017-03-31 |
$-3 |
2016-12-31 |
$-1 |
2016-09-30 |
$-1 |
2016-06-30 |
$-1 |
2016-03-31 |
$-1 |
2015-12-31 |
$-2 |
2015-09-30 |
$-1 |
2015-06-30 |
$-2 |
2015-03-31 |
$-2 |
2014-12-31 |
$-1 |
2014-09-30 |
$-1 |
2014-06-30 |
$-1 |
2014-03-31 |
$-2 |
2013-12-31 |
$-1 |
2013-09-30 |
$-1 |
2013-06-30 |
$-1 |
2013-03-31 |
$-1 |
2012-12-31 |
$-1 |
2012-09-30 |
$-1 |
2012-06-30 |
$-1 |
2012-03-31 |
$-1 |
2011-12-31 |
$-0 |
2011-09-30 |
$-1 |
2011-06-30 |
$-1 |
2011-03-31 |
$-1 |
2010-12-31 |
$-0 |
2010-09-30 |
$-0 |
2010-06-30 |
$-0 |
2010-03-31 |
$-0 |
2009-12-31 |
$-0 |
2009-09-30 |
$-0 |
2009-06-30 |
$-0 |
2009-03-31 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.244B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|